Selected article for: "immune response and response modulate"

Author: Vijayan, Veena; Mohapatra, Adityanarayan; Uthaman, Saji; Park, In-Kyu
Title: Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials
  • Document date: 2019_10_14
  • ID: 1d3xthbh_69
    Snippet: Although nanovaccines are the prominent model to treat various diseases, their efficacy to modulate our immune response against diseases can be excepted more. Some of the disadvantages of biomimetic nanovaccines are based on their stability purposes [150] . Liposomes storage becomes a major drawback as it leads to aggregation and structural destabilization [151] . Scaling up of nanovaccines is also a significant challenge due to its stability as .....
    Document: Although nanovaccines are the prominent model to treat various diseases, their efficacy to modulate our immune response against diseases can be excepted more. Some of the disadvantages of biomimetic nanovaccines are based on their stability purposes [150] . Liposomes storage becomes a major drawback as it leads to aggregation and structural destabilization [151] . Scaling up of nanovaccines is also a significant challenge due to its stability as well as cost-effective production in an efficient manner from batch to batch. Multiple loading of different components like antigens and adjuvants in a single nanoplatforms is difficult and becomes more challenging. However, these demerits of the biomimetic nanovaccines can be subjugated with appropriate ideas and advanced technology.

    Search related documents:
    Co phrase search for related documents
    • adjuvant antigen and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44
    • adjuvant antigen and single nanoplatform: 1
    • advanced technology and disease treat: 1
    • advanced technology and immune response: 1, 2, 3, 4, 5, 6
    • advanced technology and significant challenge: 1
    • appropriate idea and immune response: 1
    • biomimetic nanovaccine and immune response: 1, 2, 3, 4, 5, 6, 7